Results 271 to 280 of about 850,017 (337)

Efficacy of Immunostimulatory Adjuvants and Nano-Adjuvants in Current SARS-CoV-2 Vaccines: A Comprehensive Review. [PDF]

Health Sci Rep
Zarandi PK, Zinatizadeh MR, Ghiasi M, Rukerd MRZ, Mirkamali H, Shokri E.   +5 more
europepmc   +1 more source

The dysregulation of innate immunity by Porphyromonas gingivalis in the etiology of Alzheimer's disease

Journal of Internal Medicine, Volume 299, Issue 3, Page 328-348, March 2026.
Abstract The etiology of Alzheimer's disease (AD) remains under active debate. In this perspective, we explore the hypothesis that a primarily infection‐caused chronic dysregulation and weakening of human innate immunity via the underexpression, degradation, and inactivation of innate immune proteins necessary for direct antimicrobial effects and ...
Annelise E. Barron, Jennifer S. Lin, Mark I. Ryder, Peter Bergman   +3 more
wiley   +1 more source

Recombinant AAV vaccine expressing PEDV S1 enhances immunity with superior neonatal protection. [PDF]

NPJ Vaccines
Pang M, Ren M, Jiang D, Tu T, Zhou Y, Wang Y.   +5 more
europepmc   +1 more source

Pre-Existing Th1 Immunity Outperforms Age in Predicting Antibody Responses to SARS-CoV-2 Inactivated Vaccines. [PDF]

Adv Sci (Weinh)
Ye C, Zhang X, Qiu L, Ji J, Gu J, Jia H, Lu Y, Chen J, Meng Z, Lian J, Yao H, Zeng X, Yang Y.   +12 more
europepmc   +1 more source

Advances and Challenges in Vaccination and Therapeutic Strategies Against Japanese Encephalitis Virus. [PDF]

Pathogens
Park JY, Lee HM.
europepmc   +1 more source

Next‐Generation Bio‐Reducible Lipids Enable Enhanced Vaccine Efficacy in Malaria and Primate Models

Advanced Functional Materials, Volume 36, Issue 11, 5 February 2026.
Structure–activity relationship (SAR) optimization of bio‐reducible ionizable lipids enables the development of highly effective lipid nanoparticle (LNP) mRNA vaccines. Lead LNPs show superior tolerability and antibody responses in rodents and primates, outperforming approved COVID‐19 vaccine lipids.
Ruben De Coen, Sabah Kasmi, Shrinivas Dumbre, Lies Baekens, Elise Seynaeve, Louise Van den Hauwe, Niccolò Cantini, Aello Garantoudi, Filipe Branco Madeira, Alain Marrot, Emma Tuypens, Sofie Seghers, Anna Kuchmiy, Elisabeth Brabants, Bart Vanderborght, Ine Maes, Sarah Vandenberghe, Jessica Filtjens, Alícia Gordún Peiró, Daliya Kancheva, Ayla Debraekeleer, Florence Lambolez, Emily De Lombaerde, Yong Chen, Rafael Miyazawa Martins, Pauline Formaglio, Damya Laoui, Sofie Deschoemaeker, Bruno G. De Geest, Rogerio Amino, Stefaan De Koker   +30 more
wiley   +1 more source

West Nile Virus: Epidemiology, Surveillance, and Prophylaxis with a Comparative Insight from Italy and Iran. [PDF]

Vaccines (Basel)
Najafi S, Jojani M, Najafi K, Costanzo V, Vicidomini C, Roviello GN.   +5 more
europepmc   +1 more source

A Clinical Guidance for the Management of Patients With Hepatoid Adenocarcinoma and A Case Series

Cancer Medicine, Volume 15, Issue 2, February 2026.
ABSTRACT Hepatoid adenocarcinoma (HAC) is a rare extrahepatic tumor of non‐germ cell origin that morphologically resembles hepatocellular carcinoma (HCC). HAC has a propensity to metastasize to the liver and therefore may be mistaken for HCC. There is a lack of standardized treatment protocols, and further studies are needed to evaluate the benefit of ...
Christina Liava, Sudhakar Venkatesh, Michael S. Torbenson, Patrick S. Kamath, Moira Hilscher   +4 more
wiley   +1 more source

Research Progress in the Development of Vaccines Against <i>Riemerella anatipestifer</i>. [PDF]

Microorganisms
Lan J, Wu S, Zhao L, Li F, Xing D, Li F, Tian H, Yang X, Sun S, Wang M.   +9 more
europepmc   +1 more source